Woolf and Schoomaker also noted a relative increase over time for other causes of death, including diabetes, hypertensive diseases, mental disorders, heart diseases, transport accidents and assault. Such increases were steeper in the older population—those aged 55-64—but were evident across the board. The authors reported that a decomposition analysis of the decline in U.S. life expectancy…
Gerald G. Blackwell, MD, MBA, MedAxiom’s president and CEO, examined how different cardiology employment models look today compared to even a decade ago.
Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they…
The piece in question, which features a red heart-shaped balloon, has an unusual origin story, even by Banksy’s standards.
Specialists with Duke University Medical System will participate in a free webinar focused on their experience treating heart failure with the implantable Barostim technology from…
These findings present additional evidence that invasive imaging tests are not necessarily more effective when it comes to evaluating patients for chest pain.
New data out of Sweden show that using Abbott’s continuous glucose monitor technology is associated with a reduced risk of being hospitalized for cardiac complications.…
More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health…
Strokes and bleeding complications are more likely when PCI patients have already undergone TAVR, according to a new analysis of ACC registry data.
“These results highlight semaglutide’s early action on decreasing major cardiovascular events,” one cardiologist explained.
Strokes and bleeding complications are more likely when PCI patients have already undergone TAVR, according to a new analysis of ACC registry data.
